Log in to save to my catalogue

Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by m...

Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_10717544_2022_2030428

Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis

About this item

Full title

Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis

Publisher

England: Taylor & Francis

Journal title

Drug delivery, 2022-12, Vol.29 (1), p.440-453

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Liver fibrosis is a common pathologic stage of the development of liver failure. It has showed that exosomes loaded with therapeutic circRNAs can be manufactured in bulk by exosome secreted cells in vitro, thus enabling personalized treatment. This study aimed to investigate the role of exosome-based delivery of circDIDO1 in liver fibrosis. Levels...

Alternative Titles

Full title

Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1080_10717544_2022_2030428

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_10717544_2022_2030428

Other Identifiers

ISSN

1071-7544

E-ISSN

1521-0464

DOI

10.1080/10717544.2022.2030428

How to access this item